Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | FNTA | P49354 | 5/20 | 0.38 |
| ▸ | FNTB | P49356 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756365 | 0.87 | ALDH1A1 (0.36) | KMT2AMEN1HPGDKDM4EALDH1A1 | |
| SCHEMBL8367831 | 0.84 | L3MBTL1 (0.48) | APOBEC3GKMT2AFNTAFNTBTDP1 | |
| SCHEMBL6759221 | 0.75 | MEN1 (0.39) | APOBEC3GKMT2AFNTAFNTBMEN1 | |
| SCHEMBL8368951 | 0.74 | FNTA (0.51) | APOBEC3GFNTAFNTBL3MBTL1TAS1R3 | |
| SCHEMBL6776418 | 0.74 | FNTA (0.51) | FNTAFNTBTDP1 | |
| SCHEMBL6775544 | 0.70 | FNTA (0.48) | APOBEC3GKMT2AFNTAFNTBTDP1 | |
| SCHEMBL8936956 | 0.69 | FNTA (0.50) | FNTAFNTBL3MBTL1TAS1R3TAS1R1 | |
| SCHEMBL6760847 | 0.69 | FNTA (0.53) | KMT2AFNTAFNTBMEN1 | |
| SCHEMBL8937027 | 0.68 | L3MBTL1 (0.48) | APOBEC3GKMT2AFNTAFNTBGAA | |
| Hydrochloric Acid SCHEMBL8936982 | 0.68 | L3MBTL1 (0.47) | APOBEC3GKMT2AFNTAFNTBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040204417-A1 | Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins | PIERRE FABRE MEDICAMENT (FR) | 2004-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204417-A1 | Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins | CBR1, CBR3, HCCS | APOBEC3G 4801/4885KMT2A 3494/4885FNTA 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.